Menu
Back to User profile » Dr Jinfei Chen
Papers published by Dr Jinfei Chen:
Establishment and characterization of the GC-030-35 cell line derived from gastric hepatoid adenocarcinoma
Wei J, Xue Y, Huo X, Han R, Su X, Jin Y, Zhao W, Chen Y, Zhang H, Dai J, Chen J
Cancer Management and Research 2019, 11:1275-1287
Published Date: 8 February 2019
Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients
Han R, Wei J, Zhang H, Su X, Chu X, Chen Y, Gong Y, Wang X, Shi J, Chen J
Cancer Management and Research 2018, 10:1429-1437
Published Date: 6 June 2018
An isolated unusual digit metastasis from esophageal carcinoma: a case report
Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J
OncoTargets and Therapy 2017, 10:2449-2452
Published Date: 9 May 2017
Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
Xu W, Kuang M, Gong Y, Cao C, Chen J, Tang C
OncoTargets and Therapy 2016, 9:4833-4842
Published Date: 4 August 2016
A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma
Shen LL, Wen J, Zhao TT, Hu ZB, Song C, Gu DY, He ML, Lee NP, Xu Z, Chen JF
OncoTargets and Therapy 2016, 9:1945-1951
Published Date: 4 April 2016
Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis
Tian R, Ye HX, Zhang BG, Gu DY, Zhang BW, Teng ZP, Jin MY, Chen JF, Qi JW
OncoTargets and Therapy 2015, 8:3255-3263
Published Date: 5 November 2015